Arcadia chairman to take on interim CEO role
With effect from January 1, Kevin Comcowich has been designated Arcadia Biosciences, Inc.’s temporary chief executive officer. Arcadia Biosciences, Inc. is a manufacturer and marketer of cutting-edge, plant-based health and wellness products.
Mr. Comcowich, who was appointed board chair in 2017, will remain in that position. Prior to becoming an independent director on the Arcadia board in 2016, he served as the audit committee’s chair.
His most recent position was as Houston’s HTX Energy Fund’s portfolio manager and CEO. Prior to this, he served as the fund’s research analyst and chief investment officer (CIO) for Southport Energy Plus Partners, as well as president of Sound Energy Partners.
He graduated from the University of Indiana with a master’s in business administration after earning a bachelor’s degree from the College of the Holy Cross.
You may also like:
Food security in emerging nations: issues and remedies
Are drinks the secret to increasing cannabis use among consumers?
Managing the lack of labour for mushroom picking
“We are nearing the end of our quest for a long-term CEO to steer the business in the right direction,” Mr. Comcowich remarked, calling it an exciting moment for the business. “The amazing work being done to expand our line of fashionable, plant-based food, drink, and body care products inspires me.”
On December 31, Matthew Plavan, who has served as Arcadia’s CEO since 2019, will leave the organisation. September marked the start of Arcadia’s CEO search, which was prompted by the company’s decision to enter the consumer packaged goods market.